Consistently, we found that BCAT1 expression was low in histologically characterized grade 4 (IDH mutant) diffuse astroglioma samples, but high in GBM samples (IDH wild-type), which was negatively correlated with patients’ overall survival times (OS) (Figure 4F–N). This evidence concerns the gene BCAT1 and glioblastoma.